Blockade of the CX3CL1 ‐CX3CR1 Pathway Inhibits the Progress of Skin Inflammation, Fibrosis, and Vascular Injury in an Experimental Mouse Model of Systemic Sclerosis

ConclusionAnti ‐CX3CL1mAb therapy may be a novel approach for early skin fibrosis in inflammation‐driven fibrotic skin disorders such as SSc.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatology - June 6, 2019 Category: Rheumatology Authors: Vu H Luong, Akira Utsunomiya, Takenao Chino, Doanh H Le, Takashi Matsushita, Takashi Obara, Yoshikazu Kuboi, Naoto Ishii, Akihito Machinaga, Hideaki Ogasawara, Wataru Ikeda, Tetsu Kawano, Toshio Imai, Noritaka Oyama, Minoru Hasegawa Tags: Full Length Source Type: research